GO Term | Evidence Code | PMID |
---|---|---|
positive regulation of fatty acid oxidation | ||
lipoprotein metabolic process | ||
negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | ||
regulation of gene expression | ||
negative regulation of macrophage derived foam cell differentiation |
GO Term | Evidence Code | PMID |
---|---|---|
RNA polymerase II-specific DNA-binding transcription factor binding | ||
DNA-binding transcription factor activity | ||
nuclear receptor activity | ||
DNA-binding transcription activator activity, RNA polymerase II-specific | ||
zinc ion binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:10652 | Alzheimer's disease | |
DOID:10763 | hypertension | |
DOID:10908 | hydrocephalus | |
DOID:12351 | alcoholic hepatitis | |
DOID:1485 | cystic fibrosis | |
DOID:3146 | lipid metabolism disorder | |
DOID:3393 | coronary artery disease | |
DOID:5419 | schizophrenia | |
DOID:5844 | myocardial infarction | |
DOID:684 | hepatocellular carcinoma |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
115550780 | GADMO61572 | ||
100709869 | ORENI70084 | ||
115586305 | SPAAU46069 | ||
100497346 | Xenbase:XB-GENE-480229 | ||
109316321 | CROPO04388 | ||
113437419 | PSETE00389 | ||
103820438 | SERCA16793 | ||
100076848 | ORNAN05632 | ||
100917093 | SARHA04309 | ||
100415661 | CALJA19202 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024